πŸ‡ΊπŸ‡Έ FDA

Intelligence Β· Patent portfolio

Regeneron Ireland Designated Patents

Full USPTO pharma patent portfolio for Regeneron Ireland Designated β€” grant dates, expiration, and drug cross-links.

Patents
8,292
Expiring ≀24m
426

Quick answer

Regeneron Ireland Designated has 8,292 pharmaceutical patents in our USPTO PatentsView index (A61K/A61P). 426 expire within 24 months β€” use filters for patent-cliff planning.

Page 18 of 173

  1. US 11787804

    Compositions and methods for modulating hair growth

    Expires Mon Oct 12 2043 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  2. US 11786464

    PH responsive block copolymer compositions and micelles that inhibit MCT 1 and related proteins

    Expires Mon Oct 12 2043 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  3. US 11786597

    Ionic liquids for transdermal drug delivery

    Expires Mon Oct 12 2043 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  4. US 11786560

    Immunoisolation device

    Expires Mon Oct 12 2043 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  5. US 11786602

    ASH1L degraders and methods of treatment therewith

    Expires Mon Oct 12 2043 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  6. US 11787839

    Targeting Ξ±2Ξ΄-1-bound glutamate receptors for treating diseases and disorders

    Expires Mon Oct 12 2043 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  7. US 11780879

    Inhibition of pulmonary fibrosis with nutlin-3A and peptides

    Expires Mon Oct 05 2043 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  8. US 11779657

    Compositions and methods for mitochondrial genome editing

    Expires Mon Oct 05 2043 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  9. US 11779665

    Electrochemical flash fluorination and radiofluorination

    Expires Mon Oct 05 2043 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  10. US 11780828

    Contraceptive compounds and methods

    Expires Mon Oct 05 2043 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  11. US 11781101

    3D-printed models of biological microenvironments

    Expires Mon Oct 05 2043 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  12. US 11779653

    Multi-armed polyrotaxane platform for protected nucleic acid delivery

    Expires Mon Oct 05 2043 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  13. US 11781110

    Induction of corneal endothelial cells

    Expires Mon Oct 05 2043 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  14. US 11779559

    Compositions for treating fungal and bacterial biofilms and methods of using the same

    Expires Mon Oct 05 2043 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  15. US 11771687

    Substituted diazaspiroalkanes as androgen receptor modulators

    Expires Mon Sep 28 2043 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  16. US 11771745

    Compositions and methods for treatment of homocystinuria

    Expires Mon Sep 28 2043 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  17. US 11773143

    Conformational epitopes in respiratory syncytial virus G protein central conserved region

    Expires Mon Sep 28 2043 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  18. US 11773051

    S-enantiomers of beta-hydroxybutyrate and butanediol and methods for using same

    Expires Mon Sep 28 2043 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  19. US 11771751

    Streptococcal GlcNAc-lacking glycopolypeptides, cell wall carbohydrates, streptococcus vaccines, and methods for making and using them

    Expires Mon Sep 28 2043 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  20. US 11767303

    Compounds and methods for inhibiting viral replication and methods of treating and preventing flaviviral infections

    Expires Mon Sep 21 2043 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  21. US 11766402

    Methods for production of MSC-derived exosomes

    Expires Mon Sep 21 2043 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  22. US 11766408

    Compositions and methods for organ specific delivery of nucleic acids

    Expires Mon Sep 21 2043 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  23. US 11760858

    Dendritic macroporous hydrogels prepared by crystal templating

    Expires Mon Sep 14 2043 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  24. US 11759526

    Method and molecules

    Expires Mon Sep 14 2043 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  25. US 11760987

    Compositions and methods for the treatment or prevention of heart failure

    Expires Mon Sep 14 2043 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  26. US 11759427

    Formation of stable submicron peptide or protein particles by thin film freezing

    Expires Mon Sep 14 2043 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  27. US 11760786

    Chimeric antigen receptors targeting abnormal glycobiology

    Expires Mon Sep 14 2043 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  28. US 11760799

    Leptin antibodies

    Expires Mon Sep 14 2043 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  29. US 11759461

    Small molecule inhibitors of cancer stem cells and mesenchymal cancer types

    Expires Mon Sep 14 2043 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  30. US 11752195

    Compositions and methods of use of synthetic peptides with Mycobacterium abscessus inhibitory activity

    Expires Mon Sep 07 2043 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  31. US 11753381

    Inhibitors of receptor interacting protein kinase I for the treatment of disease

    Expires Mon Sep 07 2043 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  32. US 11753655

    Compositions and methods for treatment of neurological disorders

    Expires Mon Sep 07 2043 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  33. US 11753447

    Cyclic peptides, methods of synthesis, and methods of treatment

    Expires Mon Sep 07 2043 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  34. US 11752221

    Brush-arm star polymer imaging agents and uses thereof

    Expires Mon Sep 07 2043 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  35. US 11753623

    Compositions for treating retinal diseases and methods for making and using them

    Expires Mon Sep 07 2043 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  36. US 11746152

    Methods of cancer treatment and therapy using a combination of antibodies that bind glycosylated PD-L1

    Expires Mon Aug 31 2043 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  37. US 11745179

    Microfluidic systems and methods for lipoplex-mediated cell transfection

    Expires Mon Aug 31 2043 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  38. US 11745026

    Laser assisted wound healing protocol and system

    Expires Mon Aug 31 2043 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  39. US 11744790

    Compositions and methods for blocking ultraviolet radiation

    Expires Mon Aug 31 2043 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  40. US 11744867

    Modulation of microbial synthesis of 4-ethylphenol and 4-ethylphenyl sulfate in behavior and disease

    Expires Mon Aug 31 2043 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  41. US 11746151

    Compositions and methods for treating cancer

    Expires Mon Aug 31 2043 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  42. US 11744926

    Anti-adhesive barrier membrane using alginate and hyaluronic acid for biomedical applications

    Expires Mon Aug 31 2043 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  43. US 11738119

    Antimicrobial catheters

    Expires Mon Aug 24 2043 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  44. US 11738070

    Methods and compositions for improved cognition

    Expires Mon Aug 24 2043 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  45. US 11738116

    Expanded nanofiber structures comprising electrospun nanofibers and a plurality of holes and methods of making and use thereof

    Expires Mon Aug 24 2043 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  46. US 11739121

    EPHA2 agonists and uses thereof

    Expires Mon Aug 24 2043 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  47. US 11739162

    Side chain modified peptoids useful as structure-stabilizing coatings for biomaterials

    Expires Mon Aug 24 2043 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  48. US 11739309

    CRISPR-Cas12J effector polypeptides and methods of use thereof

    Expires Mon Aug 24 2043 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

Frequently asked questions

How many patents does Regeneron Ireland Designated have?

8,292 published patents match the current filter (all indexed). The full portfolio is indexed from USPTO PatentsView (A61K/A61P).

When do Regeneron Ireland Designated patents expire?

426 patents in the full portfolio expire within 24 months. Use the expiring filters above or open individual patent pages for grant and expiration dates.

Where does this data come from?

USPTO PatentsView bulk data filtered to pharmaceutical CPC classes (A61K, A61P), cross-linked to NovaPharmaNews company and drug profiles. See our data sources page for methodology.

Data attribution: Data sources Β· Patent directory

Drug approvals, clinical trials, M&A, event intelligence, and company updates β€” weekly.

Customize topics & region
Topics
Region

No spam. Unsubscribe anytime. See our privacy policy.